Amphotericin B Deoxycholate in Tanzania: NEMLIT level, who can prescribe it and STG references
Amphotericin B Deoxycholate is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 6 sections.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is amphotericin B Deoxycholate available on the DukaDawa pharmacy network?
Not yet. Amphotericin B Deoxycholate is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is amphotericin B Deoxycholate on the NEMLIT, and who can prescribe it?
Yes. Amphotericin B Deoxycholate is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.
- Level
- S (zonal, special and national hospitals)
- Category
- Antifungal Medicines (Anti-Infective Medicines)
- Listed forms
- Powder for injection 5mg/ml
- Page
- NEMLIT, p. 9
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is amphotericin B Deoxycholate in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention amphotericin B Deoxycholate in 6 sections, most often section 4.3.2 Protozoa and Others > Leishmaniasis (p. 119). See the STG for treatment details.
- 4.3.2 Protozoa and Others > Leishmaniasis, p. 119
- 6.5.5 Changing ART in Children Under 15 Years > Screening, Diagnosis and Management of Common Opportunistic Infections in RoC with AHD, p. 154
- 8.1.2 Infections of the Nervous System > Fungal Infections, p. 172
- 14.8 Endophthalmitis, p. 363
- 15.5.3 Granulomatous Diseases of the Nose > Rhino-orbital-cerebral mucormycosis, p. 380
- 22.12.4 Oncological Emergencies > Tumor Lysis Syndrome, p. 629
Sections that mention Amphotericin B Deoxycholate, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- Benzoic acid Compound (Whitfield’s)NEMLIT A · Not on the DukaDawa network yet
- ClotrimazoleNEMLIT A · Not on the DukaDawa network yet
- FluconazoleNEMLIT A, C · Not on the DukaDawa network yet
- FlucytosineNEMLIT S · Not on the DukaDawa network yet
- GriseofulvinNEMLIT A · Not on the DukaDawa network yet
- ItraconazoleNEMLIT D · Not on the DukaDawa network yet
- KetoconazoleNEMLIT C · Not on the DukaDawa network yet
- Liposomal Amphotericin BNEMLIT S · Not on the DukaDawa network yet
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.